As of 2025-06-24, the Fair Value of Instadose Pharma Corp (INSD) is -0.02 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.00 USD, the upside of Instadose Pharma Corp is -1,505,825.00%.
With the market price of 0.00 USD and our fair value calculation, Instadose Pharma Corp (INSD) is not a good investment. Investing in INSD stocks now will result in a potential loss of 1,505,825.00%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2017-11-30 | 2018-11-30 | 2019-11-30 | 2020-11-30 | 2021-11-30 | 5Y Avg | |
| Net income | -0.03 | -0.02 | -0.02 | -0.03 | -0.46 | -0.11 |
| YoY growth | -1,546.91% | 26.32% | 1.15% | -10.27% | -1,700.55% | -646.05% |
| Market Cap (mil) | 0.00 |
| P/E | |
| Forward P/E |
| EPS | -0.00 |
| Avg earnings growth rate | -646.05% |
| TTM earnings | -1.60 |